VEXUS Score in Septic Shock: Can It Predict Mortality

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will enroll adults with septic shock in the ICU and measure the VEXUS score at 0-4 hours, 12-24 hours, and 72 hours after shock onset. Data collected include hemodynamics, fluids and vasopressor use, renal support, ventilation, lab markers of infection, and survival status. Treatments will follow standard ICU protocols, and the study will correlate VEXUS grades with mortality and key clinical outcomes. The aim is to determine if the VEXUS score provides prognostic information beyond routine care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age\>18
* Patients monitored for septic shock in intensive care unit
* Signed informed consent

Exclusion Criteria:

* Age \<18
* Severe obesity precluding adequate ultrasonographic imaging.
* Patients in whom venous structures cannot be clearly assessed via ultrasonography due to anatomical or technical reasons (e.g., adhesions following abdominal surgery).
* Patients receiving dialysis due to chronic kidney disease or initiating dialysis for acute kidney failure.
* Chronic heart failure.
* Patients with advanced valvular insufficiency or advanced pulmonary hypertension.
* Patients with portal hypertension or advanced-stage liver cirrhosis.
* Presence of acute or chronic thrombosis in the inferior vena cava or other venous structures within the scoring area.
* Refusal to participate

Where it's running

• Antalya Training and Research Hospital
  Antalya, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Nilgun Kavrut Ozturk, Professor
• Email: kavrut@yahoo.com
• Phone: +905334196049

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Adjunctive Fludrocortisone in Septic Shock on Hydrocortisone

  In septic shock, this trial tests whether adding fludrocortisone (50 mcg or 100 mcg daily) to hydrocortisone improves survival and recovery compared with placebo.

  Recruiting at 2 sites Phase 3 The George Institute · Penrith, New South Wales and 7 other locations · NCT07898462

• Non-invasive hemodynamic guidance for sepsis care on medical wards

  This trial tests whether guiding fluid and vasopressor therapy for sepsis using non-invasive hemodynamic measurements works better than standard care.

  Recruiting at 2 sites Regione del Veneto - AULSS n. 7 Pedemontana · Pisa, Pisa and 1 other locations · NCT07863323

• Reducing Endotoxin Burden in Septic Shock Patients on CRRT with the oXiris Filter

  This trial tests whether using the oXiris hemofilter during continuous kidney replacement helps lower endotoxin levels in adults with septic shock who need CRRT.

  Recruiting Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT07807410

• Personalized Fluid Resuscitation in the Emergency Department

  This pilot test checks if a quick, non-invasive stroke-volume assessment can help ED doctors tailor IV fluids for septic patients with low blood pressure.

  Recruiting Intermountain Health Care, Inc. · Murray, Utah · NCT07779720

• Discordance between capillary refill time and oxygen use in septic shock

  This study tests whether some septic shock patients can have a normal capillary refill time but still lack tissue oxygen use, to see if that mismatch relates to 28-day survival.

  Recruiting Istanbul University - Cerrahpasa · Istanbul · NCT07774962

• Targeting upper-normal magnesium to see if norepinephrine needs drop in septic shock

  This trial tests whether keeping magnesium levels at the upper end of normal can reduce the amount and duration of norepinephrine needed in adults with septic shock.

  Recruiting Alexandria University · Alexandria, Alexandria Governorate · NCT07716956

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.